Researchers at the Icahn School of Medicine at Mount Sinai have secured a $4.1 million grant from the National Heart, Lung, and Blood Institute to investigate how everyday environmental exposures like air quality, housing, and neighborhood stress affect the health of individuals living with sickle cell disease.
The Icahn School of Medicine at Mount Sinai has received a $4.1 million grant from the National Heart, Lung, and Blood Institute, an arm of the National Institutes of Health (the funding announcement detailed). The project sets out to examine how mundane everyday factors in people’s homes and neighborhoods—ranging from food access and air quality to local temperature and housing conditions—worsen symptoms for patients with sickle cell disease.
Led by the Department of Emergency Medicine at Mount Sinai, the prospective study aims to map out the connections between daily environmental conditions and health outcomes. Sickle cell disease remains a costly single-gene disorder that causes inflammation, pain, and organ failure. Yet, despite sharing a genetic root, patients experience widely varying symptom severity, an inconsistency that has long puzzled medical researchers.
Tracking Place-Based Triggers and Real-Time Exposures
Investigators plan to pair advanced technology with biological samples to track exactly what patients encounter in their daily routines.
To capture these variables accurately, the study will deploy portable sensors that measure the particles participants breathe in real time. General satellite models will supply broader environmental data across neighborhoods, helping the team evaluate how neighborhood stressors like crime and unhealthy food options interact with a patient’s energy metabolism and inflammation levels.
When the five-year project concludes, researchers intend to make their findings accessible to the public, including co-developed neighborhood exposure maps tailored for the New York City sickle cell community. The study brings together a multidisciplinary coalition involving the Human Immune Monitoring Center, the Institute for Exposomic Research, and the Center for Sickle Cell Disease.
Broader National Efforts and Microbiome Research
The Mount Sinai initiative coincides with broader federal research pushes examining how environmental, social, and genetic factors influence sickle cell outcomes. At the National Human Genome Research Institute, investigators are actively recruiting adults and families for studies targeting symptom severity and family communication dynamics around the condition.
Vence L. Bonham, Jr., an associate investigator with the institute’s Social and Behavioral Research Branch, noted that scientists identified sickle cell anemia in 1910, yet substantial gaps remain in understanding the full spectrum of the disease. Bonham’s research team is currently recruiting adults with and without leg ulcers for the INSIGHTS Study at the NIH Clinical Center in Bethesda, Maryland, examining everything from the human microbiome to local social stressors.
Maternal Health Disparities and Sickle Cell Disease
Beyond day-to-day symptom management, recent epidemiological work highlights the profound impact sickle cell disease carries during critical life events, such as pregnancy. Research led by Nansi Boghossian and published in JAMA Pediatrics revealed that sickle cell disease significantly worsens maternal health outcomes for Black individuals in the United States.
Analyzing hospital records from more than 8.5 million deliveries across five states between 2008 and 2020 with a $3.5 million grant from the National Institute on Minority Health and Health Disparities, Boghossian’s team found that sickle cell disease accounted for 8.9 percent of the Black-White disparity in severe maternal morbidity. When excluding blood transfusions from the criteria, that contribution rose to 14.3 percent.
Those findings underscore why multidisciplinary preconception care and early risk identification remain vital for patients managing hereditary blood disorders. As institutions across the country roll out new prospective studies and community-level mapping tools, the medical community continues to piece together the complex matrix of biological and environmental drivers shaping patient health.
Продолжение темы
